enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
9.92
+0.39 (4.09%)
Feb 11, 2026, 1:55 PM EST - Market open
enGene Holdings Employees
As of October 31, 2025, enGene Holdings had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,430,512
Market Cap
664.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Prime Medicine | 214 |
| Kura Oncology | 192 |
| Rigel Pharmaceuticals | 164 |
| Alpha Tau Medical | 125 |
| Cullinan Therapeutics | 111 |
| Fulcrum Therapeutics | 45 |
ENGN News
- 7 days ago - enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 14 days ago - enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 - Seeking Alpha
- 21 days ago - enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - Business Wire
- 7 weeks ago - enGene Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 2 months ago - enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Business Wire
- 2 months ago - enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 3 months ago - enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants - Business Wire
- 3 months ago - enGene Announces Proposed Public Offering of Common Shares - Business Wire